COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

Not Applicable

Completed

• Conditions: Covid19
• Interventions: Diagnostic Test: Serological tests for SARS Cov-2

• Registration Number: NCT04723290
• Lead Sponsor: Grand Hôpital de Charleroi

Brief Summary

The management of the Grand Hôpital de Charleroi hospital authorized the performance of a serology for each member of the establishment's staff in order to better characterize the proportion of its employees who have already been in contact with the SARS CoV-2 virus for organizational and evaluation purposes symptoms.

Detailed Description

At the start of the SARS-CoV-2 pandemic, several workers had symptoms compatible with COVID-19 at a time when PCR (smear) testing was only allowed for hospitalized people. In addition, the PCR test has a fairly low sensitivity. In this context, serology can make it possible to determine whether the symptoms are indeed linked to exposure to SARS-CoV-2.

As a hospital, and in order to prepare for a possible second epidemic wave, it is also useful to know the proportion of staff members who have already been in contact with the virus for organizational purposes and symptom assessment.

.

Study Timeline

• Study Start: 2020-06-20
• Primary Completion: 2020-10-31
• Study Completion: 2020-12-31
• Study First Submitted: 2021-01-21
• Study First Submitted QC: 2021-01-21
• Study First Posted: 2021-01-25
• Status Verified: 2021-03
• Last Update Submitted: 2021-03-24
• Last Update Posted: 2021-03-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2817

Inclusion Criteria

• Be a member of the staff of the Grand Hôpital de Charleroi who wishes to participate in order to know their immunity related to SARS CoV-2 after the first wave of pandemic.

Exclusion Criteria

• Not be part of the staff of the Grand Hôpital de Charleroi.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Serological tests	Serological tests for SARS Cov-2	All staff at GHdC who want to know their level of antibodies against SARS CoV-2

Primary Outcome Measures

Name	Time	Method
Serological tests to know the level of antibodies against SARS CoV-2	up to 6 weeks	The hospital has organized several schedules and appointments for each staff member depending on the ability to analyze laboratory samples and blood draws.

Trial Locations

Locations (1)

Grand Hôpital de Charleroi; 🇧🇪 Charleroi, Hainaut, Belgium